What you should know:
1. The agreement relates to the development of robotic surgical devices.
2. Titan Medical will receive several payments totaling up to $31 million for Medtronic’s license of the devices.
3. Per the agreement, Titan Medical is still able to develop and commercialize these devices for its own business.
2. Titan Medical recently completed a nontechnical milestone under the agreement after raising $18 million of capital over a four-month period.
More articles on devices:
A simple solution to the health insurance marketplace: Authorize interstate competition
Where orthopedic PE partnerships stand in 2020
Facet joint replacement, stem cells & AR: 9 surgeons discuss new technologies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
